Axsome Therapeutics, Inc. (AXSM) vs Krystal Biotech, Inc. (KRYS)

Axsome Therapeutics, Inc. and Krystal Biotech, Inc. are both Biotechnology companies. Axsome Therapeutics, Inc. and Krystal Biotech, Inc. are of similar size ($10.3B and $10.2B). Axsome Therapeutics, Inc. has negative trailing earnings, so its P/E is not meaningful; Krystal Biotech, Inc. trades at 41.9×. Axsome Therapeutics, Inc. grew revenue faster over the last twelve months: 56.9% against 22.6%. Krystal Biotech, Inc. has the higher net margin (54.8% vs −24.7%) and the higher return on invested capital (24.1% vs 0.00%). Across the 17 metrics below, Krystal Biotech, Inc. leads on 14 and Axsome Therapeutics, Inc. on 3.